Development of Enthesopathies and Joint Structural Damage in a Murine Model of X-Linked Hypophosphatemia
X-linked hypophosphatemia (XLH) is characterized by rickets and osteomalacia, caused by inactivating mutations in the Phosphate-regulating endopeptidase homolog X-linked (PHEX) gene. With aging, adult patients develop paradoxical heterotopic calcifications of tendons and ligaments at their insertion...
Main Authors: | Carole-Anne Faraji-Bellée, Axelle Cauliez, Benjamin Salmon, Olivier Fogel, Volha Zhukouskaya, Aurélie Benoit, Thorsten Schinke, Christian Roux, Agnès Linglart, Corinne Miceli-Richard, Catherine Chaussain, Karine Briot, Claire Bardet |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2020.00854/full |
Similar Items
-
Growth hormone treatment improves final height in children with X-linked hypophosphatemia
by: Julia André, et al.
Published: (2022-12-01) -
Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone
by: Diana-Alexandra Ertl, et al.
Published: (2022-11-01) -
Dental impact of anti-fibroblast growth factor 23 therapy in X-linked hypophosphatemia
by: Elis J. Lira dos Santos, et al.
Published: (2023-12-01) -
Kbus/Idr, a mutant mouse strain with skeletal abnormalities and hypophosphatemia: Identification as an allele of 'Hyp'
by: Kimura Atsushi, et al.
Published: (2011-08-01) -
Burosumab for X-linked hypophosphatemia in children and adolescents: Opinion based on early experience in seven European countries
by: M. Zulf Mughal, et al.
Published: (2023-01-01)